SAN FRANCISCO, June 24, 2025 – Xcell Biosciences (Xcellbio), a San Francisco-based instrumentation company focused on cell and gene therapy applications, today announced a strategic collaboration with ...
Xcell Biosciences announced today the company has closed a $12 million Series A private equity financing round. The financing was led by HBM Genomics along with the continued participation of all ...
Xcell Biosciences announced today that it has expanded its development and commercial efforts around new market opportunities in immunotherapy drug research and development. The ever-growing ...
LAUSANNE, Switzerland--(BUSINESS WIRE)--NewBiologix, a technology innovation company pioneering tools for efficient, cost-effective, and scalable production of viral vectors for gene and cell therapy, ...
SAN FRANCISCO, CALIFORNIA, UNITED STATES, Dec. 09, 2025 (GLOBE NEWSWIRE) -- Xcell Biosciences Inc. (Xcellbio), an instrumentation company focused on cell and gene therapy applications, and Culture ...
MELBOURNE, Australia & PERTH, Australia, March 25, 2025--(BUSINESS WIRE)--Xcell Biosciences Australia PTY LTD (Xcellbio), an affiliate of Xcell Biosciences, Inc., a platform company focused on cell ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results